Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bading

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Theranostics|December 7, 2013
Tumor quantification in clinical positron emission tomographyBing Bai, James Bading, Peter S Conti
Vascular Pharmacology|January 18, 2003
Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesionsJasmina B Mackic, James Bading, Jorge Ghiso, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Preclinical PET Imaging of NTSR-1-Positive Tumors with <sup>64</sup>Cu- and <sup>68</sup>Ga-DOTA-Neurotensin Analogs and Therapy with an <sup>225</sup>Ac-DOTA-Neurotensin AnalogDaneng Li, Megan Minnix, Rebecca Allen, et al.
Bioconjugate Chemistry|November 9, 2007
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodiesLin Li, James Bading, Paul J Yazaki, et al.
Cancer Research|August 3, 2007
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescenceChun-Peng Liao, Chen Zhong, Gohar Saribekyan, et al.
Human Gene Therapy|June 24, 2004
Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumorsDezheng Dong, Louis Dubeau, James Bading, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing MalignanciesDavid Akhavan, Paul Yazaki, Dave Yamauchi, et al.
Blood Advances|October 12, 2021
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphomaAlex F Herrera, Joycelynne Palmer, Vikram Adhikarla, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Theranostics|December 7, 2013
Tumor quantification in clinical positron emission tomographyBing Bai, James Bading, Peter S Conti
Vascular Pharmacology|January 18, 2003
Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesionsJasmina B Mackic, James Bading, Jorge Ghiso, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Preclinical PET Imaging of NTSR-1-Positive Tumors with <sup>64</sup>Cu- and <sup>68</sup>Ga-DOTA-Neurotensin Analogs and Therapy with an <sup>225</sup>Ac-DOTA-Neurotensin AnalogDaneng Li, Megan Minnix, Rebecca Allen, et al.
Bioconjugate Chemistry|November 9, 2007
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodiesLin Li, James Bading, Paul J Yazaki, et al.
Cancer Research|August 3, 2007
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescenceChun-Peng Liao, Chen Zhong, Gohar Saribekyan, et al.
Human Gene Therapy|June 24, 2004
Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumorsDezheng Dong, Louis Dubeau, James Bading, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing MalignanciesDavid Akhavan, Paul Yazaki, Dave Yamauchi, et al.
Blood Advances|October 12, 2021
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphomaAlex F Herrera, Joycelynne Palmer, Vikram Adhikarla, et al.
Pageof 1